| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 3,206,000 | 4,139,000 | 2,948,000 | 2,864,000 | | Cost of Revenue | 2,143,000 | 2,226,000 | 1,885,000 | 1,850,000 | | | Gross Profit | 1,063,000 | 1,913,000 | 1,063,000 | 1,014,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 424,000 | 381,000 | 393,000 | 392,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 345,000 | 336,000 | 317,000 | 311,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 294,000 | 1,196,000 | 353,000 | 311,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | (4,000) | 7,000 | 23,000 | | Earnings Before Interest And Taxes | 300,000 | 1,192,000 | 360,000 | 334,000 | | Interest Expense | 99,000 | 95,000 | 90,000 | 96,000 | | Income Before Tax | 201,000 | 1,097,000 | 270,000 | 238,000 | | Income Tax Expense | 8,000 | 24,000 | 6,000 | (22,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 193,000 | 1,073,000 | 264,000 | 260,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 193,000 | 1,073,000 | 264,000 | 260,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $193,000 | $1,073,000 | $264,000 | $260,000 |
|
1.52% Nasdaq 
0.13 (0.37%) 
Income Statement
